AXIM Biotechnologies Inc (AXIM)
OTHER OTC:AXIM
AXIM Stock Chart & Stats
$0.01
<$0.01(2.94%)
At close: 4:00 PM EST
$0.01
<$0.01(2.94%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.03
Previous CloseN/A
Volume359.42K
Average Volume (3M)395.35K
Market Cap
$1.46M
Enterprise Value$9.24M
Total Cash (Recent Filing)$2.80K
Total Debt (Recent Filing)$7.55M
Price to Earnings (P/E)―
Beta0.54
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding340,456,630
10 Day Avg. Volume264,797
30 Day Avg. Volume395,350
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)-0.32
Price to Sales (P/S)0.00
P/FCF Ratio-5.31
Enterprise Value/Market Cap6.31
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-28.02
Enterprise Value/Ebitda-31.87
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
AXIM Biotechnologies News
AXIM FAQ
What was AXIM Biotechnologies Inc’s price range in the past 12 months?
AXIM Biotechnologies Inc lowest stock price was <$0.01 and its highest was $0.03 in the past 12 months.
What is AXIM Biotechnologies Inc’s market cap?
AXIM Biotechnologies Inc’s market cap is $1.46M.
When is AXIM Biotechnologies Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were AXIM Biotechnologies Inc’s earnings last quarter?
Currently, no data Available
Is AXIM Biotechnologies Inc overvalued?
According to Wall Street analysts AXIM Biotechnologies Inc’s price is currently Overvalued.
Does AXIM Biotechnologies Inc pay dividends?
AXIM Biotechnologies Inc does not currently pay dividends.
What is AXIM Biotechnologies Inc’s EPS estimate?
AXIM Biotechnologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AXIM Biotechnologies Inc have?
AXIM Biotechnologies Inc has 340,456,630 shares outstanding.
What happened to AXIM Biotechnologies Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of AXIM Biotechnologies Inc?
Currently, no hedge funds are holding shares in AXIM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
AXIM Biotechnologies Inc
AXIM Biotechnologies, Inc. specializes in the creation and distribution of advanced diagnostic solutions for healthcare, focusing on critical areas such as SARS-CoV-2 (COVID-19), ocular health, and cancer treatment. The company is currently developing rapid diagnostic assays that quantify functional neutralizing antibodies, which are essential for preventing the SARS-CoV-2 virus from attaching to human cells. Additionally, it offers serological diagnostic tests designed to detect neutralizing antibodies, thereby assessing the body's adaptive immune response to the virus, and is developing tests to identify inflammation biomarkers for the effective management of COVID-19 patients. For eye health, AXIM is pioneering quick, quantitative tear tests to measure Matrix metalloproteinase-9, an inflammatory marker associated with dry eye disease. In its oncology pipeline, the firm is advancing SBI-183, an anti-metastatic compound engineered to inhibit tumor cell growth and block the spread of cancer, as well as SPX-1009, another anti-metastatic therapy aimed at determining the levels of quiescin sulfhydryl oxidase I. Established in 2010, the company was formerly known as Axim International Inc. before officially changing its name to AXIM Biotechnologies, Inc. in July 2014, and it is headquartered in San Diego, California.